Pomegra
OlsAro, a Swedish agtech startup, raised a €5M seed round led by Industrifonden and Nordic Foodtech VC to bring salt-tolerant wheat to Bangladesh in 2027.
Key Takeaways
- OlsAro closed a €5M seed round on Oct 14, 2026, co-led by Industrifonden and Nordic Foodtech VC; valuation is undisclosed.
- Total funding now reaches about €7.5M, after a €2.5M round in April 2024 that the company now calls pre-seed.
- Salt-tolerant wheat showed up to 41% higher yield in Bangladesh trials; commercial launch is targeted for 2027.
Lead
OlsAro, a Gothenburg-based plant genetics company, announced on October 14, 2026 that it had closed a €5M (about $5.5M) seed round. Industrifonden and Nordic Foodtech VC co-led. Existing backers Future Food Fund, PINC (the venture arm of food group Paulig), AgFunder and GU Ventures also took part. The company did not disclose a valuation.
The money funds international field trials, commercial work with seed companies, and the next stage of its SeedAX platform. It also extends the company's work beyond salinity into drought tolerance and nitrogen-use efficiency.
What Does OlsAro Actually Do?
OlsAro develops wheat and other cereal varieties that keep producing in soil that would stunt conventional crops. The company is a spinout from Lund University and the University of Gothenburg, and Elén Faxö is its chief executive.
Its SeedAX platform combines genomic data, field data and transcriptomics, using AI to screen for genetic variants linked to stress tolerance. It then follows one of two routes: EMS mutagenesis, a non-GM population-based approach, or gene editing. The mutagenesis route matters commercially, because it can reach markets where transgenic crops are restricted.
How Strong Is the Evidence So Far?
The headline figure is a yield gain of up to 41% over moderately salt-tolerant varieties in Bangladesh under saline conditions. That is a best-case number, and the comparison is against a moderately tolerant benchmark, not the average farmer's seed. The company says its wheat is designed to outperform conventional varieties at salinity levels of 4 to 8 deciSiemens per meter, and up to 10.
Outside data is thinner. DCM Shriram, an Indian partner, tested three OlsAro lines at saline sites in the 2024-25 season and described results as encouraging, without published yield figures. Trials are running in Bangladesh and Pakistan at the most advanced stage, with further sites in Kenya, Egypt, Italy, Canada, Australia and India.
Why Bangladesh First?
Bangladesh offers a concentrated problem and a ready distribution channel. Roughly 1 million hectares of its farmland are affected by salinity. OlsAro has a commercialization partnership with Lal Teer Seed, described as the country's largest private biotech and seed company, and is targeting a launch in 2027.
Soil salinity affects about one-tenth of global cropland, so the addressable area is wide. A single country launch, however, will say more about farmer adoption, seed pricing and regulatory approval than any trial table. Seed businesses also tend to earn slowly: royalties and licensing fees arrive only after varieties are registered and multiplied.
What Does This Round Say About the Last One?
The April 2024 round of €2.5M carried the company through early trials and partnership building. Relabeling it pre-seed and calling the new €5M round a seed is a common move, and it fits a company that has field data but no commercial revenue. The new round doubles the capital, bringing the total to about €7.5M, which is modest for a company running trials on three continents and building a multi-trait pipeline.
Two Nordic investors co-leading, with all four existing backers returning, signals continuity more than a re-rating. The undisclosed valuation leaves open whether the step-up was large. Crop genetics is capital-hungry, and a Series A will probably depend on whether the Bangladesh launch stays on schedule.
What Comes Next for OlsAro?
The near-term milestones are variety registration and seed multiplication in Bangladesh ahead of the 2027 launch. Parallel programs on drought tolerance and nitrogen-use efficiency are meant to widen the product line beyond one trait. Rice and other cereals are listed as later targets.
The main risks are regulatory timelines in each country, the gap between trial and farm-level yields, and dependence on a small number of seed-company partners. A successful 2027 season would give the company real-world yield data and its first revenue path. A slip would push the next fundraise further out.
Outlook
OlsAro enters 2027 with €5M of fresh capital, a lead market with an estimated 1 million affected hectares, and a distribution partner in place. The 41% yield figure is promising but comes from controlled comparisons. The Bangladesh launch will show whether SeedAX can turn trial results into seed sales.
